Use of kanamycin for the isolation of auxotrophic mutants of Actinobacillus mallei.
D000188:Actinobacillus / Q000302:isolation & purification* / Q000528:radiation effects; D000596:Amino Acids / Q000378:metabolism; D003470:Culture Media; D004352:Drug Resistance, Microbial; D007612:Kanamycin / Q000494:pharmacology*; D009154:Mutation; D014466:Ultraviolet Rays
D000596:Amino Acids; D003470:Culture Media; D007612:Kanamycin